ArticleCureus2026
Demographic, Clinical, Radiological, and Cytopathological Profiles of Patients With Gallbladder Carcinoma in Tripura: A Hospital-Based Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Gallbladder carcinoma (GBC) is an aggressive malignancy characterized by rapid local invasion, delayed clinical presentation, and poor survival outcomes. Despite the high disease burden in North-East India, region-specific data on the demographic and diagnostic characteristics of GBC remain limited. Aim This study aims to describe the demographic characteristics, clinical presentation, laboratory abnormalities, radiological findings, cytopathological features, and diagnostic stages among patients with GBC in Tripura. Materials and methods This hospital-based cross-sectional study included 192 consecutive patients with cytologically confirmed GBC who were managed at a tertiary-care center in Tripura between October 2024 and September 2025. Demographic characteristics, clinical features, laboratory parameters, imaging findings, cytopathological diagnoses, and clinical stage at presentation were analyzed using descriptive statistics. Results A total of 192 patients were included, with a mean age of 61.3 ± 6.1 years. Females constituted 93.8% of the study population, and 56.3% of patients were older than 60 years. Three-fourths of patients belonged to lower-middle, upper-lower, or lower socioeconomic classes and resided in rural areas (75.0%). A non-vegetarian diet was reported by 81.3% of patients, and betel-nut chewing by 71.9%. Abdominal pain and loss of appetite were present in all patients, and significant weight loss was observed in 90.6% of patients. Jaundice and palpable gallbladder were noted in 62.5% and 81.3% of patients, respectively. Anemia was present in 96.9% of patients, and hyperbilirubinemia in 59.4%. Ultrasonography identified a gallbladder mass in 56.3% of patients, and contrast-enhanced computed tomography frequently demonstrated locally advanced disease. Cytopathological evaluation revealed adenocarcinoma in 168 (87.5%) patients. Cytopathological evaluation revealed adenocarcinoma in 168 (87.5%) patients. Clinical staging demonstrated that 75.0% of patients presented with stage III-IV disease, indicating substantial diagnostic delay. Conclusions GBC in Tripura predominantly affects elderly women and is commonly diagnosed at an advanced stage. Most patients in this cohort originated from rural and lower socioeconomic backgrounds. The high proportion of advanced-stage disease at presentation highlights the need for improved awareness, earlier diagnostic evaluation of symptomatic patients, and strengthened referral pathways in high-burden regions of North-East India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.